Programme

The conference will consist of an opening ceremony on the 3rd September followed by three full days of talks, poster presentations and opportunity to interact. Our preliminary programme is such that days will be delivered in the following format (subject to change)-

ISRA2017- Sunday evening Plenary: 5-6 pm. Mark Nelson: “Vascular Control

Time

Monday 4th

Tuesday 5th

Wednesday 6th

8.00-10.00

SESSION 1: Channels & Exchangers

SESSION 1: Regulation

SESSION 1: Structural

 

J. Jaggar (USA) – Blood pressure regulation by PKD2 (TRPP1 ) channels

 

A. Albert (UK) –          Regulation of voltage-gated Ca2+ channels and vascular contractility by MARCKS

 

E. Boedtker (Denmark)-Transport and sensing of HCO3– modify resistance artery function: consequences for blood pressure and metabolic regulation of tone

 

 B. Isakson (USA) – Pannexin1 and sympathetic control of the vasculature

T. Haas (Canada)- Modulation of angiogenesis by anti-angiogenic factors

 

K. Sward (Sweden)- Notch provides a constitutive drive for expression of soluble guanylyl cyclase in the vascular wall that is inhibited by  hypertension

 

M Cipolla (USA) – Regulation of vascular resistance in the brain: Physiology and          pathophysiology

 

Y Wang (Hong Kong) – SIRT1 expression and vascular ageing

M. Navedo (USA) -Purinergic signaling in diabetic resistance arteries

 

M. Mederos Y Schnitzler (Germany)- The role of GPCRs for mechanosensation in arteries

 

T. Jepps (Denmark) – Regulation of arterial tone by ancillary KCNE  subunits

 

 

L. Martinez-Lemus (USA) –
Relationships between cell adhesion and vascular smooth muscle cytoskeletal structures in arteriolar vasoconstriction and remodeling.

 

10.00-10.20

Coffee

Coffee

Coffee

 

10.20-12.30

SESSION 2: Interaction other cells

SESSION 2: Interaction other cells

SESSION 2: Interaction other cells

 

T. Longden  (USA) –   Capillary-to-arteriole communication regulates blood flow into the brain

 

 

C. Tran (Canada)- Alteration to cerebral hemodynamics modifies astrocytes Ca2+ activity in awake, behaving mice

 

C. Hall (UK) – Regulation of cerebral blood flow by pericytes

 

G. Whitely (UK) – Spiral artery remodeling in early pregnancy

L. Santana (USA)-Local control of vascular smooth muscle

 

 

A. Hobbs (UK) –     Pivotal vascular homeostatic role for        endothelium – derived C-type natriuretic peptide.

 

 

G. Drummond (Australia) – B cell mediated immunity and hypertension

 

 Speaker 4 – from submisisons

M.  Fernández-Alfonso (Spain)-Regional differences in perivascular adipose tissue impacting vascular homeostasis

 

E Eringa (Amsterdam)-Inflammation of         perivascular adipose tissue as a driver of microvascular dysfunction in obesity and  prediabetes.

 

M De Silva (Australia) –
Activation of the Brain Renin Angiotensin System Selectively Impairs Cerebrovascular Function

 

S Davidge (Canada) – Pregnancy complications and programming of vascular dysfunction in adult offspring

12:30-13:30

LUNCH

LUNCH

LUNCH

 

13:30-16:00

Free time

Free time

Plenary Speaker

U. Pohl-A hitchhikers guide to the ISRA galaxy

 

Early Career Researchers

 C Wilson – Mitochondria / endothelium (Strathclyde UK)

 

S Saxton (UK) – Mechanisms of perivascular adipose tissue dysfunction in obesity and restoration using exercise

 

Speaker 3 – From submissions

 

Speaker 4 – From submissions

16:00-18:00

Moderated posters and vendors

Moderated posters and vendors

18:00-19:30

DINNER

DINNER

GALA DINNER AND PRIZES

19:30-20:15

Special: C.  Aalkjaer – The remarkable hemodynamic system of giraffes

Special: R Touyz Vessels at the heart of hypertension

20:15-21:30

SESSION 3: Clinical scenarios

SESSION 3: Clinical scenarios

 

H. Li (Germany) – Role of perivascular adipose tissue in obesity-induced vascular    dysfunction

 

D.  Stepp  (USA) -Novel mechanisms of altered vasomotor tone in obesity

 

A. Briones (Spain) – Novel mechanisms of vascular damage in hypertension

M. Bennett (UK) – Life, death and old age : role of vascular smooth muscle cells in                atherosclerosis

 

 T. Guzik  (UK)-Inflammation as a therapeutic target in hypertension and vascular dysfunction

 

Speaker 3– from submissions

Comments are closed